Episode 39: Abbott FreeStyle Libre - Accuracy, Simplicity and What's Next

Suggest guests or get in contactMichael Skarlatos from Abbott UK Medical Affairs joins John Pemberton for the second manufacturer episode of the CGM Series. A former diabetes specialist dietitian at University Hospitals of Leicester, Michael brings real clinical experience to an honest breakdown of the FreeStyle Libre 2 Plus and 3 Plus.This episode covers:- Why Abbott accuracy data qualifies these sensors for insulin dosing: ICGM approved, 20/20 performance ~95-96%, outside-40/40 error rate 0.2%- What 70% smaller means in practice: form factor, stigma, and the all-in-one applicator on Libre 3 Plus- Pump integrations now and the roadmap: CamAPS FX, Omnipod 5, and what is coming- Libreview: why Abbott moved off Glooko and what population health management enables- Libreview Pro in SystmOne and EMIS with SNOMED-coded CGM metrics- A critical data nuance: glucose measured every minute on the patient app but recorded every 5 minutes in clinical downloads- Continuous ketone monitoring: what Abbott has in development and who benefits mostCHAPTERS00:00 Introduction and CGM Series overview00:57 Michaels background and Leicester NHS Trust02:25 Moving from NHS to Abbott Medical Affairs03:27 Accuracy credentials: ICGM approval and 20/20 performance05:44 FreeStyle Libre 3 Plus: size and form factor09:25 Pump integrations: CamAPS FX, Omnipod 5, and the roadmap10:19 ICGM interoperability: US vs CE marking in Europe12:05 Fifteen-day wear period12:28 Abbott market history: free samples and patient-led adoption14:04 Simplicity of onboarding and multi-language support16:58 Starter clinics: taking onboarding off the HCP19:33 Libreview and population health management23:21 EHR integration, SNOMED codes, and QOF implications25:46 Practical tips: Bluetooth connectivity and the app cache29:23 Minute-by-minute data vs five-minute trend recording30:58 Low glucose event thresholds and hypo underreporting31:42 Continuous ketone monitoring: what is coming from Abbott37:52 CGM beyond type 1 and patient advocacy40:17 Closing thoughtsLINKSShow notes: https://theglucoseneverlies.com/episode-38-freestyle-libre-abbott/YouTube: https://youtu.be/IW1sa5APHU8CGM Series: https://theglucoseneverlies.com/10-13-cgm-series/GNL Explorers: https://theglucoseneverliDisclaimerThis podcast is for education and informational purposes only. It does not constitute medical advice and is not a substitute for individualised care.The Glucose Never Lies® is independent by designWe do not accept sponsorships and advertising. We operate via education grants and donations from listeners who value independence. So, consider:Buying the GNL a Coffee:https://www.buymeacoffee.com/jspfree2EnquiriesCollaboration: John Pemberton — [email protected]: Anjanee Kohli — [email protected] The Glucose Never Lies®Website: https://theglucoseneverlies.com/Instagram: https://www.instagram.com/theglucoseneverliesLinkedIn: https://www.linkedin.com/company/theglucoseneverliesLinkedIn: John Pemberton: https://www.linkedin.com/in/john-pemberton-587104361/X: https://twitter.com/GlucoseNLiesDisclaimer This content is for informational purposes only and does not constitute medical advice.© The Glucose Never Lies Ltd. All rights reserved.